Milestone Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.About MIST
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients.
CEOJoseph G. Oliveto
CEOJoseph G. Oliveto
Employees33
Employees33
HeadquartersMontréal, Québec
HeadquartersMontréal, Québec
Founded2003
Founded2003
Employees33
Employees33
MIST Key Statistics
Market cap224.42M
Market cap224.42M
Price-Earnings ratio-3.03
Price-Earnings ratio-3.03
Dividend yield—
Dividend yield—
Average volume3.38M
Average volume3.38M
High today$2.71
High today$2.71
Low today$2.58
Low today$2.58
Open price$2.66
Open price$2.66
Volume3.47M
Volume3.47M
52 Week high$2.77
52 Week high$2.77
52 Week low$0.6254
52 Week low$0.6254
Stock Snapshot
Milestone Pharmaceuticals(MIST) stock is priced at $2.65, giving the company a market capitalization of 224.42M. It carries a P/E multiple of -3.03.
On 2025-12-04, Milestone Pharmaceuticals(MIST) stock traded between a low of $2.58 and a high of $2.71. Shares are currently priced at $2.65, which is +2.9% above the low and -2.1% below the high.
The Milestone Pharmaceuticals(MIST)'s current trading volume is 3.47M, compared to an average daily volume of 3.38M.
In the last year, Milestone Pharmaceuticals(MIST) shares hit a 52-week high of $2.77 and a 52-week low of $0.63.
In the last year, Milestone Pharmaceuticals(MIST) shares hit a 52-week high of $2.77 and a 52-week low of $0.63.
People also own
Based on the portfolios of people who own MIST. This list is generated using Robinhood data, and it’s not a recommendation.